A Phase III Efficacy Study of the Symptomatic Treatment of Seasonal Allergic Rhinitis With Bilastine
Status:
Completed
Trial end date:
2004-02-01
Target enrollment:
Participant gender:
Summary
The objective of the study was to determine the efficacy and tolerability of 20 mg of
Bilastine, compared to Desloratadine and placebo for the treatment of Seasonal Allergic
Rhinitis.